Clinical Trials Browser

Phase 2 × Colorectal Neoplasms × Standard of Care × Clear all

NCT07023289 2026-03-13

A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

Phase 2 Recruiting

Gastrointestinal

Neoplasms, Colorectal Neoplasms

NCT06528990 2026-03-05

Telehealth Intervention for Ostomy Self-Management

Phase 2 Recruiting

GastrointestinalGenitourinary

Urinary Bladder Neoplasms, Colorectal Neoplasms

NCT03844620 2026-01-09

Circulating Cell-Free Tumor DNA Testing in Guiding Treatment for Patients With Advanced or Metastatic Colorectal Cancer

Phase 2 Active not recruiting

Gastrointestinal

Colorectal Neoplasms

NCT04680260 2024-08-14

OPTIMISE

Phase 2 Recruiting

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT02448810 2021-05-25

Phase 2a Study of BAX69 and 5-FU/Leucovorin or Panitumumab Versus Standard of Care in Subjects With Metastatic Colorectal Cancer

Phase 2 Terminated

115 enrolled 22 charts

Gastrointestinal

Colorectal Neoplasms